These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15669191)

  • 21. High frequency of thrombophilic disorders in women with recurrent fetal miscarriage.
    Onderoglu L; Baykal C; Al RA; Demirtas E; Deren O; Gurgey A
    Clin Exp Obstet Gynecol; 2006; 33(1):50-4. PubMed ID: 16761541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hereditary disorders of the protein C system in central artery and branch arteriolar occlusions].
    Greiner K; Hafner G; Prellwitz W; Pfeiffer N
    Klin Monbl Augenheilkd; 1999 Jul; 215(1):33-6. PubMed ID: 10448635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natural anticoagulants deficiency and the risk of venous thromboembolism: a meta-analysis of observational studies.
    Di Minno MN; Ambrosino P; Ageno W; Rosendaal F; Di Minno G; Dentali F
    Thromb Res; 2015 May; 135(5):923-32. PubMed ID: 25784135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prevalence of hereditary thrombophilia in the Trakya region of Turkey.
    Demir M; Vural O; Sunar H; Altun A; Yorulmaz F; Ozbay G
    Yonsei Med J; 2000 Aug; 41(4):436-40. PubMed ID: 10992803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Haemostatic changes and acquired activated protein C resistance in normal pregnancy.
    Mahieu B; Jacobs N; Mahieu S; Naelaerts K; Vertessen F; Weyler J; Jacquemyn Y; Van der Planken M
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):685-8. PubMed ID: 17890957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of a highly specific functional test for the detection of factor V Leiden.
    Quenhenberger P; Handler S; Mannhalter C; Pabinger-Fasching I; Speiser W
    Int J Clin Lab Res; 2000; 30(3):113-7. PubMed ID: 11196068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of activated protein C resistance in acute myocardial infarction in Japan.
    Hayashi K; Sone T; Kondoh J; Tsuboi H; Sassa H; Numaguchi Y; Toki Y; Okumura K; Ito T; Hayakawa T
    Jpn Heart J; 1997 Nov; 38(6):769-78. PubMed ID: 9486929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of ischemic stroke in young Indians: is thrombophilia profiling a way out?
    Chatterjee T; Gupta N; Choudhry VP; Behari M; Saxena R; Ashraf MZ
    Blood Coagul Fibrinolysis; 2013 Jun; 24(4):449-53. PubMed ID: 23337710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deficiencies of natural anticoagulants, protein C, protein S, and antithrombin.
    Lipe B; Ornstein DL
    Circulation; 2011 Oct; 124(14):e365-8. PubMed ID: 21969320
    [No Abstract]   [Full Text] [Related]  

  • 30. Thrombosis in congenital deficiencies of AT III, protein C or protein S: a study of 44 children.
    Toumi NH; Khaldi F; Ben Becheur S; Hammou A; Bouttière B; Sampol J; Boukef K
    Hematol Cell Ther; 1997 Dec; 39(6):295-9. PubMed ID: 9497888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activated protein C resistance in normal and pre-eclamptic pregnancies.
    Paternoster DM; Stella A; Simioni P; Girolami A; Snijders D
    Gynecol Obstet Invest; 2002; 54(3):145-9. PubMed ID: 12571435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein C, protein S and antithrombin III deficiencies in retinal vein occlusion.
    Tekeli O; Gürsel E; Buyurgan H
    Acta Ophthalmol Scand; 1999 Dec; 77(6):628-30. PubMed ID: 10634552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A possible role for activated protein C resistance in patients with first and second trimester pregnancy failure.
    Tal J; Schliamser LM; Leibovitz Z; Ohel G; Attias D
    Hum Reprod; 1999 Jun; 14(6):1624-7. PubMed ID: 10357988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resistance to activated protein C due to mutated factor V as a novel cause of inherited thrombophilia.
    De Stefano V; Leone G
    Haematologica; 1995; 80(4):344-56. PubMed ID: 7590506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel mutation (g2172-->c) in the factor V gene in a Chinese family with hereditary activated protein C resistance.
    Cai H; Hua B; Fan L; Wang Q; Wang S; Zhao Y
    Thromb Res; 2010 Jun; 125(6):545-8. PubMed ID: 20304467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between adverse pregnancy outcomes and maternal factor V G1691A (Leiden) and prothrombin G20210A genotypes in women with a history of recurrent idiopathic miscarriages.
    Mahjoub T; Mtiraoui N; Tamim H; Hizem S; Finan RR; Nsiri B; Almawi WY
    Am J Hematol; 2005 Sep; 80(1):12-9. PubMed ID: 16138341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lupus anticoagulant interference in activated protein C resistance testing: in vitro phenomenon or in vivo pathophysiologic effect?
    Shen YM; Cimo ML; Bai Y; Frenkel E; Sarode R
    Clin Appl Thromb Hemost; 2011; 17(6):E190-5. PubMed ID: 21406411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High long-term absolute risk of recurrent venous thromboembolism in patients with hereditary deficiencies of protein S, protein C or antithrombin.
    Brouwer JL; Lijfering WM; Ten Kate MK; Kluin-Nelemans HC; Veeger NJ; van der Meer J
    Thromb Haemost; 2009 Jan; 101(1):93-9. PubMed ID: 19132194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The deficiencies of protein C, protein S and antithrombin III in patients with retinal vein occlusion: a Turkish sample.
    Ates O
    Clin Lab Haematol; 2006 Dec; 28(6):391-2. PubMed ID: 17105492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Laboratory assessment of hypercoagulable state. A study in a group of patients with venous thromboembolism born in Chioggia.
    Gessoni G; Valverde S; Canistro R; Trabuio E; Antico F; Manoni F
    Minerva Med; 2007 Apr; 98(2):89-93. PubMed ID: 17519850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.